High content screening for neurodegenerative drug discovery
High content screening for neurodegenerative drug discovery enables multiparametric analysis of neuronal cells to identify therapeutic candidates. By combining automated imaging with advanced data analysis, researchers can assess cell morphology, protein localization, and synaptic activity. This approach supports high-throughput evaluation of neurotoxicity, regeneration, and signaling pathways,...
0 Comments 0 Shares 131 Views 0 Reviews